| Name | Value |
|---|---|
| Revenues | 2.2M |
| Cost of Revenue | 0.0M |
| Gross Profit | 2.2M |
| Operating Expense | 41.7M |
| Operating I/L | -39.6M |
| Other Income/Expense | 0.0M |
| Interest Income | 0.0M |
| Pretax | -39.6M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -39.6M |
Tekla Healthcare Investors is a closed-ended equity mutual fund managed by Tekla Capital Management LLC. The fund invests in global public equity markets, focusing on healthcare companies in biotechnology, medical devices, and pharmaceuticals. It primarily targets growth stocks of small cap companies, using fundamental analysis to assess market position, management expertise, and funding capabilities. The fund generates revenue through capital appreciation and dividends from its investment portfolio. It benchmarks its performance against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index.